NATtrol SARS-CoV-2 (recombinant) Stock is formulated with purified, intact bacterial cells containing synthetic SARS-CoV-2 sequence. The cells have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol SARS-CoV-2 (recombinant) Stock in a purified protein matrix.

NATtrol SARS-Cov-2 (recombinant) Stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARS-COV-2 N gene. NATtrol SARS-Cov-2 (recombinant) Stock can also be used for validation of clinical assays, development of diagnostic tests and training of laboratory personnel.

This version targets the CDC gene. A second version that targets the WHO gene soon. Please contact customer service for more details.

+2? to +8? C.
Product Insert.pdf

Material Safety Data Sheet.pdf